Clinical Trial: Tapering of Inhaled Corticosteroids in Tezepelumab-treated Asthma patieNts: Impact on Clinical Outcomes: Inhaled Corticosteroids Will be Tapered According to Standard Care, in Severe Asthma Patients Which Have Started Treatment With Tezepelumab

U.S., July 21 -- ClinicalTrials.gov registry received information related to the study (NCT07713498) titled 'Tapering of Inhaled Corticosteroids in Tezepelumab-treated Asthma patieNts: Impact on Clinical Outcomes: Inhaled Corticosteroids Will be Tapered According to Standard Care, in Severe Asthma Patients Which Have Started Treatment With Tezepelumab' on May 01.

Brief Summary: To evaluate the relationship between starting tezepelumab treatment followed by tapering of inhaled corticosteroid (ICS) and ICS dose, metabolic outcomes, asthma control and exacerbation rate in a real world setting

Study Start Date: May 01

Study Type: OBSERVATIONAL

Condition: Severe Asthma

Intervention: OTHER: Tapering of inhaled corticosteroid (ICS) treatmen...